Professional Documents
Culture Documents
Veeva Overview For Interview
Veeva Overview For Interview
Q&A
Life Sciences: overview &
2020 industry challenges
What are Life Sciences?
“Companies in the fields of biotechnology, pharmaceuticals,
biomedical technologies, life systems technologies, nutraceuticals,
cosmeceuticals, food processing, environmental, biomedical
devices, and organizations and institutions that devote most of
their efforts in the various stages of research, development,
technology transfer and commercialization.”
2020 Challenges of Life Sciences
Our Values: Do the Right Thing, Customer Success, Employee Success and Speed
Veeva’s role in the Life Science industry
Leader in cloud-based software for the global Life Sciences industry
CDMS
Clinical Trials & CDMS
role in Life Sciences
Clinical trials overview
• Phase I studies usually test new drugs for the first time in a small group of people
to evaluate a safe dosage range and identify side effects
• Phase II studies test treatments that have been found to be safe in phase I but now
need a larger group of human subjects to monitor for any adverse effects
• Phase III studies are conducted on larger populations and in different regions and
countries, and are often the step right before a new treatment is approved
• Phase IV studies take place after country approval and there is a need for further
testing in a wide population over a longer timeframe
Veeva’s suite of clinical applications is built on the Veeva Vault Platform, the first
cloud platform built from the ground up to meet the rigorous usability, scalability,
performance, validation and security requirements of the life sciences industry.